Sign In
Last checked at 
13 Jun 2025 14:16
13 June 2025
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 13 June 2025, David Lapp, a Non-Executive Director, purchased 24,590 ordinary shares in the Company at an average price of USD 12.28 per ordinary share via the US OTC Markets.
Ends
Fever-Tree
Investor queries
Ann Morris-Gibbons, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024
Nominated Advisor and Broker - Investec Bank plc
David Flin I +44 (0)20 7597 5970
Corporate Broker - Jefferies International Limited
Ed Matthews I Richard Taylor I +44 (0)20 7029 8000
Financial PR advisers - FGS Global
Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233
About Fever-Tree:
Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name | David Lapp | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | Non-Executive Director | ||||||
b) | Initial notification/Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name |
| ||||||
b) | LEI | 2138007AJRLHRVQZLD07 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification code |
| ||||||
b) | Nature of the transaction | Acquisition of FQVTF equity via OTC | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information | As above | ||||||
e) | Date of the transaction | 13 June 2025 | ||||||
f) | Place of the transaction | US OTC Market | ||||||
Follow the stocks
